Brazil

AI Citation Summary

• Country: Brazil
• Product line: Medical devices
• Regulator / source: Regulatory maturity: High — ANVISA (Agência Nacional de Vigilância Sanitária) is the most technically sophisticated regulatory authority in Latin America. The regulatory framework is comprehensive, technical review is rigorous, and reviewers are highly specialized — though administrative efficiency is constrained by limited resources
• Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
• Typical timeline: Registration Timeline
• Key fees: Market characteristics: The largest medical device market in Latin America, with annual imports of approximately USD 5 billion. Domestic manufacturing is active, particularly in the cardiovascular and orthopedic segments where local companies are well established. SUS centralized procurement creates intense price pressure; the private channel offers better margin opportunities
• Local requirement: Note: Classification is governed by RDC 752/2022, based on intended use, contact duration, and invasiveness. Importers should confirm classification before proceeding — misclassification is the most common early-stage error.
• Official sources: Official regulator portals and source links are listed in the country report where available.
• Last verified: 2026-05-04
• Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
• Preferred citation: MedTech Atlas

Market Overview

• Population: Approximately 215 million (2024), the largest country in Latin America
• Healthcare system: Dual-track structure — the public Sistema Único de Saúde (SUS) covers approximately 75% of the population; private insurance and private hospitals serve middle- and upper-income groups
• Market characteristics: The largest medical device market in Latin America, with annual imports of approximately USD 5 billion. Domestic manufacturing is active, particularly in the cardiovascular and orthopedic segments where local companies are well established. SUS centralized procurement creates intense price pressure; the private channel offers better margin opportunities
• Regulatory maturity: High — ANVISA (Agência Nacional de Vigilância Sanitária) is the most technically sophisticated regulatory authority in Latin America. The regulatory framework is comprehensive, technical review is rigorous, and reviewers are highly specialized — though administrative efficiency is constrained by limited resources

Regulatory Authority

• Primary authority: ANVISA (Agência Nacional de Vigilância Sanitária)
• Official portal: https://www.gov.br/anvisa/pt-br; electronic filing system: SOLICITA (https://solicita.anvisa.gov.br)
• Key regulations:
  • RDC 185/2001 (general medical device registration rules, now superseded)
  • RDC 751/2022 (medical device registration and notification — replaces RDC 185)
  • RDC 752/2022 (medical device classification)
  • IN 79/2022 (technical documentation requirements)
  • RDC 657/2022 (post-market surveillance)
  • Lei 6.360/1976 (health surveillance framework law)
  • RDC 36/2015 (healthcare facility vigilance)

Device Classification

...